The Use of Capsule Endoscopy for Assessment of Neuroendocrine Tumors of Unknown Primary Tumor Location
#681
Introduction: Recent studies suggest that capsule endoscopy (CE) should be implemented in diagnostic work-up in patients suspected to have small bowel (SB) tumors. SB accounts for the primary tumor site in 80%-85% of patients with intestinal neuroendocrine tumors (NET). In 10%-15% of patients diagnosed with metastasized NET, the primary tumor site remains obscure.
Aim(s): To evaluate the efficacy of CE in detection of SB NETs in this setting.
Materials and methods: From 2010-2012, seven patients with histologically confirmed metastasized NET and unknown localization of the primary tumor were referred to our institution. In all patients CT or MRI and somatostatin receptor imaging were carried out. All patients underwent CE. Findings on CE were recorded. Those patients with univocal findings were considered for surgery.
Conference: 10th Annual ENETSConcerence (2013)
Presenting Author:
Authors: Drymousis P, Martin J, Smith G, Kinross J, Frilling A,
Keywords: capsule endoscopy, small bowel NETs, NETs of unknown primary,
To read the full abstract, please log into your ENETS Member account.